Verano Holdings (VRNO) Current Leases (2021 - 2026)
Verano Holdings' (VRNO) quarterly Current Leases came in at $12.3 million in Q1 2026, up 7.78% year-on-year from $11.4 million in Q1 2025, and up 2.65% on a QoQ basis from $12.0 million in Q4 2025.
Verano Holdings (VRNO) Current Leases (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Current Leases data on file, last reported at $12.3 million in Q1 2026.
- On a quarterly basis, Current Leases rose 7.78% year-over-year to $12.3 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 7.78% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 6.48% from the prior year.
- Current Leases for Q1 2026 stood at $12.3 million, up from $12.0 million in the prior quarter.
- Over the last five years, Current Leases for VRNO reached as high as $12.3 million in Q1 2026 and fell as low as $8.0 million in Q2 2022.
- Historically, Current Leases has averaged $10.3 million across 5 years, with a median of $10.0 million in 2024.
- Across the five-year window, Current Leases surged 35.44% in 2022 and advanced 5.98% in 2025, its largest moves.
- Year by year, Current Leases stood at $8.9 million in 2022, then gained by 9.69% to $9.8 million in 2023, then advanced by 15.38% to $11.2 million in 2024, then grew by 6.48% to $12.0 million in 2025, then climbed by 2.65% to $12.3 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $12.3 million in Q1 2026, $12.0 million in Q4 2025, and $11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 12.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.30 Mn |
| Dec 31, 2025 | 11.98 Mn |
| Sep 30, 2025 | 11.67 Mn |
| Jun 30, 2025 | 11.40 Mn |
| Mar 31, 2025 | 11.41 Mn |
| Dec 31, 2024 | 11.25 Mn |
| Sep 30, 2024 | 11.01 Mn |
| Jun 30, 2024 | 10.21 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 9.75 Mn |
| Sep 30, 2023 | 9.45 Mn |
| Jun 30, 2023 | 9.37 Mn |
| Mar 31, 2023 | 9.24 Mn |
| Dec 31, 2022 | 8.89 Mn |
| Sep 30, 2022 | 8.53 Mn |
| Jun 30, 2022 | 7.96 Mn |
| Dec 31, 2021 | 6.56 Mn |